Total Payments
$53,785
2024 Payments
$750.00
Companies
10
Transactions
55
Medicare Patients
1,887
Medicare Billing
$177,878
Payment Breakdown by Category
Consulting$47,211 (87.8%)
Travel$3,053 (5.7%)
Other$2,168 (4.0%)
Food & Beverage$1,334 (2.5%)
Education$19.26 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $47,211 | 22 | 87.8% |
| Travel and Lodging | $3,053 | 14 | 5.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,168 | 1 | 4.0% |
| Food and Beverage | $1,334 | 15 | 2.5% |
| Education | $19.26 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $15,531 | 9 | $0 (2019) |
| Ironwood Pharmaceuticals, Inc | $13,716 | 15 | $0 (2019) |
| RedHill Biopharma Inc. | $8,397 | 3 | $0 (2022) |
| Merck Sharp & Dohme LLC | $5,750 | 8 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $4,966 | 4 | $0 (2019) |
| Shire North American Group Inc | $3,011 | 8 | $0 (2017) |
| Astellas Pharma Inc | $1,451 | 2 | $0 (2018) |
| DiaSorin Inc. | $800.00 | 1 | $0 (2018) |
| Synergy Pharmaceuticals Inc | $150.06 | 4 | $0 (2018) |
| Boston Scientific Corporation | $13.46 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $750.00 | 1 | Merck Sharp & Dohme LLC ($750.00) |
| 2023 | $750.00 | 1 | Merck Sharp & Dohme LLC ($750.00) |
| 2022 | $6,872 | 3 | RedHill Biopharma Inc. ($5,622) |
| 2021 | $4,275 | 3 | RedHill Biopharma Inc. ($2,775) |
| 2020 | $13.46 | 1 | Boston Scientific Corporation ($13.46) |
| 2019 | $11,524 | 6 | Ironwood Pharmaceuticals, Inc ($5,604) |
| 2018 | $16,976 | 14 | Otsuka America Pharmaceutical, Inc. ($11,924) |
| 2017 | $12,625 | 26 | Ironwood Pharmaceuticals, Inc ($7,587) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 07/19/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 09/26/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 09/02/2022 | RedHill Biopharma Inc. | Talicia (Drug) | Consulting Fee | Cash or cash equivalent | $5,550.00 | General |
| Category: Antibiotic | ||||||
| 05/22/2022 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $72.42 | General |
| Category: Antibiotic | ||||||
| 09/29/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 09/02/2021 | RedHill Biopharma Inc. | Talicia (Drug) | Consulting Fee | Cash or cash equivalent | $2,775.00 | General |
| Category: Antibiotic | ||||||
| 05/12/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 02/27/2020 | Boston Scientific Corporation | GENERAL - BILIARY DEVICES (Device) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: BILIARY DEVICES | ||||||
| 10/09/2019 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Consulting Fee | Cash or cash equivalent | $5,150.00 | General |
| Category: Gastroenterology | ||||||
| 07/20/2019 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | In-kind items and services | $249.68 | General |
| Category: Gastroenterology | ||||||
| 07/20/2019 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Travel and Lodging | In-kind items and services | $204.06 | General |
| Category: Gastroenterology | ||||||
| 05/08/2019 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 01/08/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | BREATHTEK (Device) | Consulting Fee | Cash or cash equivalent | $3,252.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/08/2019 | Otsuka America Pharmaceutical, Inc. | BREATHTEK (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,168.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Education | In-kind items and services | $6.42 | General |
| Category: Gastroenterology | ||||||
| 11/16/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Education | In-kind items and services | $6.42 | General |
| Category: Gastroenterology | ||||||
| 09/24/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Education | In-kind items and services | $6.42 | General |
| Category: Gastroenterology | ||||||
| 09/20/2018 | Ironwood Pharmaceuticals, Inc | — | Travel and Lodging | In-kind items and services | $265.22 | General |
| 09/20/2018 | Ironwood Pharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $160.04 | General |
| 09/20/2018 | Ironwood Pharmaceuticals, Inc | — | Travel and Lodging | In-kind items and services | $99.66 | General |
| 08/16/2018 | Otsuka America Pharmaceutical, Inc. | BREATHTEK (Device) | Consulting Fee | Cash or cash equivalent | $9,756.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/02/2018 | Astellas Pharma Inc | — | Consulting Fee | Cash or cash equivalent | $1,425.00 | General |
| 06/21/2018 | Otsuka Pharmaceutical Development & Commercialization, Inc. | BREATHTEK (Device) | Consulting Fee | Cash or cash equivalent | $1,626.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/07/2018 | DiaSorin Inc. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 14 | 476 | 498 | $887,224 | $47,809 |
| 2021 | 17 | 728 | 758 | $1.2M | $69,293 |
| 2020 | 15 | 683 | 723 | $1.1M | $60,776 |
Total Patients
1,887
Total Services
1,979
Medicare Billing
$177,878
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 72 | 72 | $300,960 | $12,379 | 4.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $31,602 | $6,815 | 21.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 39 | 39 | $130,650 | $4,724 | 3.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 23 | 23 | $64,860 | $4,012 | 6.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 22 | 22 | $62,040 | $3,599 | 5.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 47 | 49 | $124,460 | $3,546 | 2.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 44 | $21,120 | $3,379 | 16.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 23 | 23 | $68,770 | $2,942 | 4.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $10,120 | $1,804 | 17.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $43,200 | $1,497 | 3.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $6,215 | $1,134 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 14 | $4,382 | $877.72 | 20.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $4,565 | $723.26 | 15.8% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 102 | 102 | $14,280 | $376.82 | 2.6% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 85 | 85 | $338,300 | $16,154 | 4.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 62 | 62 | $39,990 | $8,902 | 22.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 53 | 77 | $34,650 | $6,070 | 17.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 56 | 56 | $178,080 | $6,018 | 3.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 32 | 32 | $86,080 | $5,512 | 6.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 65 | 65 | $156,650 | $4,950 | 3.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 19 | 19 | $51,110 | $3,380 | 6.6% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 42 | 42 | $86,100 | $3,065 | 3.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 38 | $11,210 | $2,808 | 25.1% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 36 | 37 | $14,615 | $2,696 | 18.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 29 | 29 | $12,470 | $2,386 | 19.1% |
About Dr. Nimish Vakil, M.D
Dr. Nimish Vakil, M.D is a Specialist healthcare provider based in Summit, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336124585.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nimish Vakil, M.D has received a total of $53,785 in payments from pharmaceutical and medical device companies, with $750.00 received in 2024. These payments were reported across 55 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($47,211).
As a Medicare-enrolled provider, Vakil has provided services to 1,887 Medicare beneficiaries, totaling 1,979 services with total Medicare billing of $177,878. Data is available for 3 years (2020–2022), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Gastroenterology
- Location Summit, WI
- Active Since 12/09/2005
- Last Updated 11/30/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1336124585
Products in Payments
- BREATHTEK (Device) $20,409
- Talicia (Drug) $8,397
- LINZESS (Drug) $5,615
- Linzess (Drug) $5,604
- IW-3718 $222.07
- Trulance (Drug) $150.06
- GENERAL - BILIARY DEVICES (Device) $13.46
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Summit
Robert Sussman, M.d, M.D
Specialist — Payments: $667,104
Specialist $667,104
Robert Restifo, D.o, D.O
Specialist — Payments: $9,252
Specialist $9,252
Dr. Dilip Shah, M.d, M.D
Specialist — Payments: $4,013
Specialist $4,013
Chaitali Gupte, M.d, M.D
Specialist — Payments: $1,413
Specialist $1,413
Dr. Marc Mandel, M.d, M.D
Specialist — Payments: $568.55
Specialist $568.55
Dr. John Gianis, M.d, M.D
Specialist — Payments: $463.68
Specialist $463.68